Walvax Biotechnology announced that the revenue for the first quarter of 2025 was 0.462 billion yuan, a decrease of 22.93% year-on-year; net income was 2.6462 million yuan, a decrease of 81.27% year-on-year.
Walvax Biotechnology: In the first quarter of 2025, net income was 2.6462 million yuan, a decrease of 81.27% year-on-year.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Market Insights
Discussing
中美大降關稅！如何抓住市場交易機會？
中美關稅超預期降溫，市場迎來久違狂歡。5月12日下午，中方公佈中美日內瓦經貿會談聯合聲明，美方取消共計91%的加徵關稅，中方相應取消91%的反制關稅，美方暫停實施24%的「對等關稅」，中方相應暫停實施24%的反制關稅。聲明公佈後，港美股當日應聲暴漲，修復至關稅前水平。13日，特朗
Food流油
Apr 14 15:43
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"
Investment Course
Choose stocks based on financial reports
Quickly master financial season learning guidelines
When the financial season comes, company stock prices are the most likely to rise and fall, and many excellent investors will see the financial season as a good
[2025.2] How should NVIDIA's performance be viewed? The key indicator to watch for short-term stock prices is this.
NVIDIA has been one of the best-performing Technology giants in the US stock market over the past two years, and since 2024, its stock price has experienced sig
How to view Tesla's performance in January 2025? Pay attention to these four key points.
It's earnings season for US stocks again. The performance of giant companies not only affects their own stock prices but also influences the overall trend of th